Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.

Motomu HashimotoMoritoshi FuruWararu YamamotoTakanori FujimuraRyota HaraMasaki KatayamaAkira OhnishiKengo AkashiShuzo YoshidaKoji NagaiYonsu SonHideki AmuroToru HiranoKosuke EbinaRyuji UozumiHiromu ItoMasao TanakaKoichiro OhmuraTakao FujiiTsuneyo Mimori

Published in: Arthritis research & therapy (2018)

BFR can be achieved in some patients with RA after bDMARD discontinuation in clinical practice. Use of TNFi(mAb) or CTLA4-Ig, sustained remission, Boolean remission, and no glucocorticoid use at the time of bDMARD discontinuation are advantageous for achieving BFR.

Keyphrases

disease activity
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
systemic lupus erythematosus
clinical practice
ulcerative colitis
interstitial lung disease
monoclonal antibody